These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5020104)

  • 1. [Study of the blood activity of ceruloplasmin and erythropoietin in hypo- and aplastic anemia].
    Faĭnshteĭn FE; Chizhova AI; Vinokurova GP; Sushchenko IB; Lipats AA
    Probl Gematol Pereliv Krovi; 1972 Jan; 17(1):15-20. PubMed ID: 5020104
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior and significance of plasmatic erythropoietin in aplastic anemia].
    Gambaro GC; Fresco G; Aranzulla G
    Arch Maragliano Patol Clin; 1970; 26(2):139-52. PubMed ID: 5537632
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavior and significance of plasma erythropoietin in aplastic anemias].
    Gambaro GC; Aranzulla G; Fresco
    Haematologica; 1969; 54(7):511-21. PubMed ID: 4986884
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serum erythropoietin levels and bone marrow hematopoiesis in patients with aplastic anemia].
    Ogawa T
    Rinsho Ketsueki; 1996 Jul; 37(7):604-9. PubMed ID: 8779780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on erythropoietin activity in blood in anemias with hypoplastic and hyperplastic bone marrow].
    Essers U; Mann H
    Med Welt; 1970 Oct; 43():1851-2. PubMed ID: 5475555
    [No Abstract]   [Full Text] [Related]  

  • 6. [Indices of ceruloplasmin activity in patients with hematologic diseases and portal hypertension].
    Slivinskiĭ BP
    Probl Gematol Pereliv Krovi; 1968 Apr; 13(4):31-2. PubMed ID: 5753946
    [No Abstract]   [Full Text] [Related]  

  • 7. [Erythropoietins and ceruloplasmin in acute renal insufficiency].
    Agranenko VA; Komarov LS; Chizhova AI
    Ter Arkh; 1968 Jun; 40(6):77-81. PubMed ID: 5739216
    [No Abstract]   [Full Text] [Related]  

  • 8. [A study of ceruloplasmin activity in patients with hypoplastic anemia].
    Chizhova AI
    Probl Gematol Pereliv Krovi; 1967 Dec; 12(12):13-6. PubMed ID: 4894324
    [No Abstract]   [Full Text] [Related]  

  • 9. [Erythropoietin in human pathology].
    Boivin P; Fauvert R
    Pathol Biol; 1967; 15(11):677-85. PubMed ID: 4860745
    [No Abstract]   [Full Text] [Related]  

  • 10. A study of hypoplastic anaemia.
    Garewal G; Mohanty D; Das KC
    Indian J Med Res; 1981 Apr; 73():558-70. PubMed ID: 7262928
    [No Abstract]   [Full Text] [Related]  

  • 11. [Behavior and significance of plasma erythropoietin in anemias during chronic renal insufficiency].
    Gambaro GC; Fresco G; Aranzulla G
    Haematologica; 1969; 54(12):863-74. PubMed ID: 4993253
    [No Abstract]   [Full Text] [Related]  

  • 12. [Estimation of the hemoglobin resistant to alkaline denaturation in aplastic anemia (author's transl)].
    Zhang RF
    Zhonghua Nei Ke Za Zhi; 1981 Sep; 20(9):556-8. PubMed ID: 6174278
    [No Abstract]   [Full Text] [Related]  

  • 13. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in patients with aplastic anemia and refractory anemia.
    Bessho M; Jinnai I; Hirashima K; Saito M; Murohashi I; Ino H; Tsuji M; Fukuda M; Maruyama M; Kusumoto S
    Stem Cells; 1994 Nov; 12(6):604-15. PubMed ID: 7533579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of Hypoplastic anemia with ceruloplasmin--discussions on its effectiveness and mechanism (author's transl)].
    Hoshino T; Uchida A; Takahashi T; Horiuchi T
    Rinsho Ketsueki; 1980 Apr; 21(4):498-505. PubMed ID: 7411880
    [No Abstract]   [Full Text] [Related]  

  • 15. [Aplastic anemia in renal insufficiency--an inhibitory effect of the uremic serum on the erythropoetin?].
    Essers U; Brass H; Spicher K
    Klin Wochenschr; 1970 Jan; 48(2):92-5. PubMed ID: 5521219
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sustained long-term complete remission in an elderly aplastic anemia patient after cessation of combined therapy consisting of granulocyte-colony stimulating factor and erythropoietin].
    Yasuyama M; Kawauchi K; Sugiyama H; Ohkawa S
    Rinsho Ketsueki; 2000 Jan; 41(1):42-7. PubMed ID: 10695398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pluripotent hemopoietic precursors in vitro (CFUMIX) in aplastic anemia.
    Hara H; Kai S; Fushimi M; Taniwaki S; Okamoto T; Ohe Y; Fujita S; Noguchi K; Senba M; Hamano T; Kanamaru A; Nagai K
    Exp Hematol; 1980 Oct; 8(9):1165-71. PubMed ID: 7227471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The thromboelastogram in healthy persons and in patients with hypoplastic and aplastic anemia].
    Alekseev NA; Abdulkadyrov KM; Klimova KN
    Ter Arkh; 1966 Aug; 38(8):81-6. PubMed ID: 5996197
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical study of GM-CSF in patients with aplastic anemia and myelodysplastic syndrome. (CSF39-300 Study Group)].
    Kitamura K; Asano S; Mizoguchi H; Takaku F
    Rinsho Ketsueki; 1993 Dec; 34(12):1540-9. PubMed ID: 8295327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietic effect of plasma from patients with advanced cancer.
    Firat D; Banzon J
    Cancer Res; 1971 Oct; 31(10):1355-9. PubMed ID: 5106807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.